VanEck Associates’s VanEck CLO ETF CLOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28K Buy
532
+16
+3% +$844 ﹤0.01% 1353
2025
Q4
$27K Buy
516
+92
+22% +$4.87K ﹤0.01% 1369
2025
Q3
$23K Sell
424
-28
-6% -$1.48K ﹤0.01% 1368
2025
Q2
$24K Hold
452
﹤0.01% 1350
2025
Q1
$24K Buy
452
+15
+3% +$794 ﹤0.01% 1332
2024
Q4
$23K Buy
437
+199
+84% +$10.5K ﹤0.01% 1332
2024
Q3
$13K Sell
238
-215
-47% -$11.4K ﹤0.01% 1324
2024
Q2
$24K Buy
+453
New +$23.9K ﹤0.01% 1321
2023
Q3
Sell
-80,000
Closed -$4.13M 1399
2023
Q2
$4.13M Hold
80,000
0.01% 556
2023
Q1
$4.11M Sell
80,000
-240,000
-75% -$12.3M 0.01% 528
2022
Q4
$16.2M Buy
320,000
+120,000
+60% +$6.02M 0.04% 264
2022
Q3
$10.1M Hold
200,000
0.03% 307
2022
Q2
$10M Buy
+200,000
New +$10.1M 0.03% 333

Other funds holding CLOI

VanEck Associates's CLOI Position: Q1 2026 in Review

VanEck Associates increased its VanEck CLO ETF (CLOI) stake by 3.1% in Q1 2026, buying an estimated $844 and bringing the position to 532 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #1353.

VanEck Associates first reported a position in CLOI in Q2 2022 and has held it in 13 quarters since. The position peaked at $16.2M in Q4 2022. 167 funds tracked by Wall St. Rank hold CLOI as of Q1 2026.

  • VanEck Associates held 532 shares of VanEck CLO ETF worth $28K as of Q1 2026.
  • VanEck Associates bought 16 VanEck CLO ETF shares in Q1 2026, an estimated $844.
  • VanEck CLO ETF made up ﹤0.01% of VanEck Associates's portfolio in Q1 2026, its #1353 holding.
  • VanEck Associates first reported a position in VanEck CLO ETF in Q2 2022 and has held it in 13 quarters since.
  • VanEck Associates's VanEck CLO ETF position peaked at $16.2M in Q4 2022.
  • 167 funds tracked by Wall St. Rank held VanEck CLO ETF as of Q1 2026.

Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.